IL33 and Barrett esophagus: Studies have shown that chronic inflammation may significantly increase the risk of BE development in the esophagus, and IL-33 contributes to the development of esophageal inflammation; it is reasonable to speculate that IL-33 may play a key role in the initiation of EAC.